William McKee Net Worth & Insider Trades
William McKee - Chief Financial Officer, C4 Therapeutics, Inc
What is William McKee's Net Worth?
The current estimated net worth of C4 Therapeutics, Inc's Chief Financial Officer, William McKee, is estimated to be about $1.19M . William McKee owns about 5,263 units of C4 Therapeutics, Inc common stock. Recently at C4 Therapeutics, Inc, William McKee has sold an estimated value of $0 worth.
What is William McKee's Past Insider Trading?
William McKee's largest purchase order was 5,263 units , worth over $100K on October 6, 2020. In total, William McKee has made about 1 transaction recently at C4 Therapeutics, Inc. William McKee usually trades in October, with the busiest year in 2020.
WILLIAM MCKEE
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was William McKee's Salary in 2020?
William McKee received compensation valued at about $2,099,745 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of option awards of $1,025,271 , other compensation of $1,074,474 .
C4 Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Andrew J. Hirsch | 2020 | $167,850 | - | $20,659,713 | $98,800 | $5,608 | $20,931,971 |
Andrew J. Hirsch | 2019 | - | - | - | - | - | - |
Marc A. Cohen | 2020 | - | - | $9,063,399 | - | $69,500 | $9,132,899 |
Marc A. Cohen | 2019 | - | - | - | - | - | - |
Andrew Phillips, Ph.D. | 2020 | $94,500 | - | - | - | $523,775 | $618,275 |
Andrew Phillips, Ph.D. | 2019 | $520,000 | - | $3,377,316 | $260,000 | $36,359 | $4,193,675 |
William T. McKee | 2020 | - | - | $1,025,271 | - | $1,074,474 | $2,099,745 |
William T. McKee | 2019 | - | - | - | - | - | - |
Adam S. Crystal, M.D., Ph.D. | 2020 | $409,750 | $61,000 | $941,770 | $184,800 | $6,000 | $1,603,320 |
Adam S. Crystal, M.D., Ph.D. | 2019 | $344,250 | $100,000 | $1,118,835 | $120,488 | $6,373 | $1,689,946 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1662579/000156459021020538/cccc-def14a_20210615.htm
What are C4 Therapeutics, Inc's Past Insider Trades?
C4 Therapeutics, Inc's most recent insider trade came on February 10, 2023 by Utpal Koppikar who bought 5,667 units worth $31.74K . In the last 3 years, insiders at C4 Therapeutics, Inc have sold an estimated value of $16.93M and bought an estimated value of $1.65M worth of shares. Insider trading is most common in February and October, with the busiest year in 2021. The most active traders at the company are Carl Kenneth Anderson, Director, Malcolm Salter, Director, and Adam Crystal, Chief Medical Officer .
C4 Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |